Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure ...

Sri Aurobindo Institute of Pharmacy (SAIP), Indore, successfully hosted a National Conference on "Pharma Innovations: ...

The number of clinical trials in which AI designed or repurposed molecules, or targeted diseases, has more than doubled since ...

LB Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing novel therapies for the treatment of ...

Middle molecules with a molecular weight of more than 1,000 are difficult to synthesize due to multiple steps and time-consuming nature, demanding the development of a new approach that can overcome ...

Draft Pharma Policy 2025 of Odisha encourages ease of doing businesses: Peethaambaran Kunnathoor, Chennai Wednesday, February 12, 2025, 08:00 Hrs [IST] Following the ‘Make-in-Od ...

Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...

Anthos Therapeutics was set up by Blackstone Life Sciences after it licensed abelacimab drug from Novartis in 2019 ...